Recital 6, Decision_act (EU) 2022/2326

In forcesince 24 Nov 2022

As the applicant has withdrawn the application for approval of epsilon-metofluthrin for use in biocidal products of product-type 19, there is no biocidal product to be evaluated. Consequently, the European Chemicals Agency did not prepare an opinion. Finally, as there is no biocidal product of product-type 19 containing epsilon-metofluthrin that may be expected to meet the criteria laid down in Article 19(1), point (b), of Regulation (EU) No 528/2012, the conditions laid down in Article 4(1) of that Regulation are not met. Considering also the need to ensure that treated articles treated with or intentionally incorporating epsilon-metofluthrin for product-type 19 are no longer placed on the Union market, it is appropriate not to approve epsilon-metofluthrin for use in biocidal products of product-type 19.